<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Second Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan In order to elucidate the role of <z:chebi fb="3" ids="16335">adenosine</z:chebi> in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>, the possible protective effects of <z:chebi fb="3" ids="16335">adenosine</z:chebi> on ischemic brain injury were investigated in a rat model of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> both in vitro and in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>Exogenous <z:chebi fb="3" ids="16335">adenosine</z:chebi> dose-dependently rescued cortical neuronal cells from injury after <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation in vitro </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> (1 mM) also significantly reduced <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo>/<z:mp ids='MP_0005039'>hypoxia</z:mp>-induced <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release from the hippocampal slice </plain></SENT>
<SENT sid="3" pm="."><plain>In a rat model of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), extracellular <z:chebi fb="3" ids="16335">adenosine</z:chebi> concentration was increased immediately after occlusion, and then returned to the baseline by 30 min after reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> infusion through a microdialysis probe into the ipsilateral striatum (1 mM <z:chebi fb="3" ids="16335">adenosine</z:chebi>, 2 microl min(-1), total 4.5 h from the occlusion to 3 h after reperfusion) showed a significant improvement in the neurological outcome, and about 25% reduction of <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, although the effect did not reach statistical significance, compared with the vehicle-treated group at 20 h after 90 min of MCAO </plain></SENT>
<SENT sid="5" pm="."><plain>These results demonstrated the neuroprotective effect of <z:chebi fb="3" ids="16335">adenosine</z:chebi> against ischemic brain injury both in vitro and in vivo, suggesting the possible therapeutic application of <z:chebi fb="3" ids="16335">adenosine</z:chebi> regulating agents, which inhibit <z:chebi fb="3" ids="16335">adenosine</z:chebi> uptake or metabolism to enhance or maintain extracellular endogenous <z:chebi fb="3" ids="16335">adenosine</z:chebi> levels, for <z:hpo ids='HP_0001297'>stroke</z:hpo> treatment </plain></SENT>
</text></document>